Celularity Inc.

NASDAQ: CELUW · Real-Time Price · USD
0.06
0.00 (0.00%)
At close: May 23, 2025, 2:23 PM

Celularity Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
License Royalty and Other Revenue 13.74M 13.15M 6.1M 7.33M
License Royalty and Other Revenue Growth +4.53% +115.49% -16.74% n/a
Product Revenue 35.34M 5.44M 9.05M 9.17M
Product Revenue Growth +549.44% -39.87% -1.34% n/a
Service Revenue 5.14M n/a n/a n/a
Service Revenue Growth n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selling, General, and Administrative Revenue 16.06M 12.65M 15.91M 14.03M 13.07M 10.75M 12.83M 13.93M 19.08M 14.91M 15.57M 16.46M 13.21M 21.64M 28.86M 7.63M 5.97M 8.33M 7.59M 241.64K 246.96K 202K 115.25K 121
Selling, General, and Administrative Revenue Growth +26.94% -20.48% +13.39% +7.35% +21.59% -16.20% -7.95% -26.97% +27.99% -4.28% -5.38% +24.62% -38.98% -25.01% +278.48% +27.67% -28.27% +9.77% +3039.39% -2.16% +22.26% +75.27% +95147.93% n/a
Research and Development Revenue 3.83M 3.92M 3.8M 5.84M -272K 5.18M 8.6M 16.95M 10.99M 20.35M 25.35M 21.67M 24.69M 23.77M 22.91M 16.99M 13.92M 11.22M 15.8M 11.76M 12.75M n/a n/a n/a
Research and Development Revenue Growth -2.22% +3.03% -34.96% -2248.16% -105.25% -39.77% -49.24% +54.24% -46.00% -19.72% +16.96% -12.21% +3.88% +3.73% +34.85% +22.02% +24.13% -29.02% +34.36% -7.75% n/a n/a n/a n/a